InvestorsHub Logo
Followers 23
Posts 1330
Boards Moderated 1
Alias Born 09/25/2018

Re: HappyLibrarian post# 294540

Monday, 07/13/2020 12:10:16 AM

Monday, July 13, 2020 12:10:16 AM

Post# of 700509
Tweaks to the process might explain why nwbo added the section on "equivalency studies" to its list of potential risks in SEC filings.

Changes in manufacturing methods for DCVax-L could require us to conduct equivalency studies and/or additional clinical trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News